{"id": "article-135305_0", "title": "CNS Tuberculosis -- Continuing Education Activity", "content": "Tuberculosis is prevalent worldwide. One catastrophic manifestation of extrapulmonary tuberculosis is central nervous system (CNS) involvement,\u00a0which can present as\u00a0either tubercular meningitis (TBM), CNS tuberculoma, or spinal arachnoiditis. CNS tuberculosis (CNS-TB) may develop\u00a0from hematogenous spread or the rupture of subependymal or meningeal tubercular foci.\u00a0The condition carries the highest morbidity and mortality among all\u00a0tuberculosis forms.", "contents": "CNS Tuberculosis -- Continuing Education Activity. Tuberculosis is prevalent worldwide. One catastrophic manifestation of extrapulmonary tuberculosis is central nervous system (CNS) involvement,\u00a0which can present as\u00a0either tubercular meningitis (TBM), CNS tuberculoma, or spinal arachnoiditis. CNS tuberculosis (CNS-TB) may develop\u00a0from hematogenous spread or the rupture of subependymal or meningeal tubercular foci.\u00a0The condition carries the highest morbidity and mortality among all\u00a0tuberculosis forms."}
{"id": "article-135305_1", "title": "CNS Tuberculosis -- Continuing Education Activity", "content": "Diagnosing CNS-TB poses challenges due to its paucibacillary nature and the limitations of conventional diagnostic methods. Clinical scoring systems exist but have flaws, emphasizing the need for a comprehensive approach, including history, examination, cerebrospinal fluid (CSF) analysis, and imaging. Though confirmatory evidence from CSF is difficult to obtain, molecular techniques like polymerase chain reaction offer valuable assistance.", "contents": "CNS Tuberculosis -- Continuing Education Activity. Diagnosing CNS-TB poses challenges due to its paucibacillary nature and the limitations of conventional diagnostic methods. Clinical scoring systems exist but have flaws, emphasizing the need for a comprehensive approach, including history, examination, cerebrospinal fluid (CSF) analysis, and imaging. Though confirmatory evidence from CSF is difficult to obtain, molecular techniques like polymerase chain reaction offer valuable assistance."}
{"id": "article-135305_2", "title": "CNS Tuberculosis -- Continuing Education Activity", "content": "Epidemiological factors and extraneural infections can\u00a0help identify patients with\u00a0CNS-TB. CSF examination, including microscopy and culture, remains crucial. However, newer techniques like Xpert Mycobacterium tuberculosis /rifampin, loop-mediated isothermal amplification assay, and metagenomic sequencing show promise. Imaging, particularly magnetic resonance, is pivotal in\u00a0detecting characteristic findings, such as basilar leptomeningeal enhancement and tuberculomas, aiding in timely and accurate diagnosis.", "contents": "CNS Tuberculosis -- Continuing Education Activity. Epidemiological factors and extraneural infections can\u00a0help identify patients with\u00a0CNS-TB. CSF examination, including microscopy and culture, remains crucial. However, newer techniques like Xpert Mycobacterium tuberculosis /rifampin, loop-mediated isothermal amplification assay, and metagenomic sequencing show promise. Imaging, particularly magnetic resonance, is pivotal in\u00a0detecting characteristic findings, such as basilar leptomeningeal enhancement and tuberculomas, aiding in timely and accurate diagnosis."}
{"id": "article-135305_3", "title": "CNS Tuberculosis -- Continuing Education Activity", "content": "This activity for healthcare professionals is designed to improve learners' competence in evaluating and treating CNS-TB. Participants gain a deeper understanding of the condition's pathophysiology, nuanced presentations, diagnostic approaches, and therapeutic strategies. Learners become prepared to collaborate effectively within an interprofessional team\u00a0to enhance outcomes for patients with CNS-TB.", "contents": "CNS Tuberculosis -- Continuing Education Activity. This activity for healthcare professionals is designed to improve learners' competence in evaluating and treating CNS-TB. Participants gain a deeper understanding of the condition's pathophysiology, nuanced presentations, diagnostic approaches, and therapeutic strategies. Learners become prepared to collaborate effectively within an interprofessional team\u00a0to enhance outcomes for patients with CNS-TB."}
{"id": "article-135305_4", "title": "CNS Tuberculosis -- Continuing Education Activity", "content": "Objectives: Identify\u00a0the\u00a0signs and symptoms indicative of central nervous system tuberculosis. Create a clinically guided diagnostic plan for an individual with suspected central nervous system tuberculosis. Implement a personalized management strategy for a patient diagnosed with\u00a0central nervous system tuberculosis. Collaborate with the interprofessional team to educate, treat, and monitor patients with\u00a0central nervous system tuberculosis\u00a0to improve\u00a0health outcomes. Access free multiple choice questions on this topic.", "contents": "CNS Tuberculosis -- Continuing Education Activity. Objectives: Identify\u00a0the\u00a0signs and symptoms indicative of central nervous system tuberculosis. Create a clinically guided diagnostic plan for an individual with suspected central nervous system tuberculosis. Implement a personalized management strategy for a patient diagnosed with\u00a0central nervous system tuberculosis. Collaborate with the interprofessional team to educate, treat, and monitor patients with\u00a0central nervous system tuberculosis\u00a0to improve\u00a0health outcomes. Access free multiple choice questions on this topic."}
{"id": "article-135305_5", "title": "CNS Tuberculosis -- Introduction", "content": "Mycobacterium tuberculosis is responsible for 5.9% of community-acquired central nervous system (CNS) infections worldwide. [1] Neurological or\u00a0CNS tuberculosis (CNS-TB) may take 1 of 3 clinicopathological forms: Tubercular meningitis (TBM),\u00a0affecting\u00a0the CNS\u00a0diffusely CNS tuberculoma, the focal type Spinal arachnoiditis, also\u00a0called\u00a0\"tuberculous\u00a0radiculomyelitis\" (TBRM),\u00a0involving\u00a0only the spine [2]", "contents": "CNS Tuberculosis -- Introduction. Mycobacterium tuberculosis is responsible for 5.9% of community-acquired central nervous system (CNS) infections worldwide. [1] Neurological or\u00a0CNS tuberculosis (CNS-TB) may take 1 of 3 clinicopathological forms: Tubercular meningitis (TBM),\u00a0affecting\u00a0the CNS\u00a0diffusely CNS tuberculoma, the focal type Spinal arachnoiditis, also\u00a0called\u00a0\"tuberculous\u00a0radiculomyelitis\" (TBRM),\u00a0involving\u00a0only the spine [2]"}
{"id": "article-135305_6", "title": "CNS Tuberculosis -- Introduction", "content": "Of these forms, TBM predominates as it causes\u00a070% to 80% of\u00a0CNS-TB\u00a0infections.\u00a0TBM\u00a0presents\u00a0with\u00a0subacute-to-chronic meningitis signs and symptoms, with disease severity commensurate with illness duration. [3] Diagnosis is fraught with challenges and is often delayed due to the varied and nonspecific presentations. [4] Besides the clinical clues, diagnostic indicators in cerebrospinal fluid (CSF) include mononuclear pleocytosis, low sugar values, and high protein concentrations. Identifying Mycobacterium tuberculosis (MTB) in CSF by staining, culture methods, and molecular analysis is confirmatory but may be challenging. [5]", "contents": "CNS Tuberculosis -- Introduction. Of these forms, TBM predominates as it causes\u00a070% to 80% of\u00a0CNS-TB\u00a0infections.\u00a0TBM\u00a0presents\u00a0with\u00a0subacute-to-chronic meningitis signs and symptoms, with disease severity commensurate with illness duration. [3] Diagnosis is fraught with challenges and is often delayed due to the varied and nonspecific presentations. [4] Besides the clinical clues, diagnostic indicators in cerebrospinal fluid (CSF) include mononuclear pleocytosis, low sugar values, and high protein concentrations. Identifying Mycobacterium tuberculosis (MTB) in CSF by staining, culture methods, and molecular analysis is confirmatory but may be challenging. [5]"}
{"id": "article-135305_7", "title": "CNS Tuberculosis -- Introduction", "content": "Advanced radiological imaging techniques are usually of great assistance in making presumptive diagnoses. Vasculitic infarcts, cranial nerve (CN) palsies, multiple neurological deficits, and hydrocephalus frequently complicate CNS-TB. A strong clinical suspicion is typically enough to start prompt antitubercular therapy.\u00a0The\u00a04-drug regimen of isoniazid, rifampin, pyrazinamide, and ethambutol with adjunctive corticosteroid reduces morbidity and mortality.\u00a0However,\u00a0CNS-TB diagnosis and management may be complicated by drug resistance, immune reconstitution inflammatory syndrome (IRIS), and HIV coinfection.", "contents": "CNS Tuberculosis -- Introduction. Advanced radiological imaging techniques are usually of great assistance in making presumptive diagnoses. Vasculitic infarcts, cranial nerve (CN) palsies, multiple neurological deficits, and hydrocephalus frequently complicate CNS-TB. A strong clinical suspicion is typically enough to start prompt antitubercular therapy.\u00a0The\u00a04-drug regimen of isoniazid, rifampin, pyrazinamide, and ethambutol with adjunctive corticosteroid reduces morbidity and mortality.\u00a0However,\u00a0CNS-TB diagnosis and management may be complicated by drug resistance, immune reconstitution inflammatory syndrome (IRIS), and HIV coinfection."}
{"id": "article-135305_8", "title": "CNS Tuberculosis -- Introduction", "content": "Treatment efficacy depends upon the timing. Multiple factors determine the prognosis, the most important being the TBM clinical stage at\u00a0initial\u00a0presentation. Untreated or unrecognized TBM may cause death within 5\u00a0to 8 weeks of\u00a0disease\u00a0onset.", "contents": "CNS Tuberculosis -- Introduction. Treatment efficacy depends upon the timing. Multiple factors determine the prognosis, the most important being the TBM clinical stage at\u00a0initial\u00a0presentation. Untreated or unrecognized TBM may cause death within 5\u00a0to 8 weeks of\u00a0disease\u00a0onset."}
{"id": "article-135305_9", "title": "CNS Tuberculosis -- Introduction -- Normal Protective Barriers of the Central Nervous System", "content": "The CNS is shielded from potentially harmful blood-borne bacteria by\u00a02\u00a0vascular barriers: the blood-brain barrier (BBB) and blood-CSF barrier (BCSFB). The BBB, primarily consisting of brain microvascular endothelial cells, regulates the passage of substances between the blood and CNS with tight junctions and specialized transport mechanisms. Supporting elements like pericytes and astrocytes also play crucial roles in maintaining BBB integrity. In contrast, the BCSFB is formed by choroid plexus epithelial cells and the arachnoid membrane, similarly employing tight junctions to control the exchange between blood and CSF.", "contents": "CNS Tuberculosis -- Introduction -- Normal Protective Barriers of the Central Nervous System. The CNS is shielded from potentially harmful blood-borne bacteria by\u00a02\u00a0vascular barriers: the blood-brain barrier (BBB) and blood-CSF barrier (BCSFB). The BBB, primarily consisting of brain microvascular endothelial cells, regulates the passage of substances between the blood and CNS with tight junctions and specialized transport mechanisms. Supporting elements like pericytes and astrocytes also play crucial roles in maintaining BBB integrity. In contrast, the BCSFB is formed by choroid plexus epithelial cells and the arachnoid membrane, similarly employing tight junctions to control the exchange between blood and CSF."}
{"id": "article-135305_10", "title": "CNS Tuberculosis -- Introduction -- Normal Protective Barriers of the Central Nervous System", "content": "However, in vitro and animal models\u00a0have shown that\u00a0MTB can invade brain endothelial cells by rearranging cellular actin molecules. The MTB gene Rv0931c is implicated in promoting CNS infection by facilitating bacillary endothelial adhesion. MTB may also exploit the\u00a0\"Trojan horse\" mechanism, utilizing infected macrophages and neutrophils to traverse the BBB. [6]", "contents": "CNS Tuberculosis -- Introduction -- Normal Protective Barriers of the Central Nervous System. However, in vitro and animal models\u00a0have shown that\u00a0MTB can invade brain endothelial cells by rearranging cellular actin molecules. The MTB gene Rv0931c is implicated in promoting CNS infection by facilitating bacillary endothelial adhesion. MTB may also exploit the\u00a0\"Trojan horse\" mechanism, utilizing infected macrophages and neutrophils to traverse the BBB. [6]"}
{"id": "article-135305_11", "title": "CNS Tuberculosis -- Etiology", "content": "MTB is the organism responsible for CNS-TB. This alcohol and acid-fast bacillus\u00a0may be visualized microscopically\u00a0using the Ziehl-Neelsen, auramine-rhodamine, and Kinyoun stains. The etiological contribution of the other\u00a04 Mycobacterium species in causing CNS-TB has not been established. Humans are the only known MTB hosts\u00a0or reservoirs. Infection is primarily acquired through airborne aerosols from infected individuals.", "contents": "CNS Tuberculosis -- Etiology. MTB is the organism responsible for CNS-TB. This alcohol and acid-fast bacillus\u00a0may be visualized microscopically\u00a0using the Ziehl-Neelsen, auramine-rhodamine, and Kinyoun stains. The etiological contribution of the other\u00a04 Mycobacterium species in causing CNS-TB has not been established. Humans are the only known MTB hosts\u00a0or reservoirs. Infection is primarily acquired through airborne aerosols from infected individuals."}
{"id": "article-135305_12", "title": "CNS Tuberculosis -- Epidemiology", "content": "Around\u00a025% to 30% of the human population is infected with MTB. CNS-TB is reported in 1% to 2% of individuals with active tuberculosis. [7] CNS-TB accounts for 5% to 8% of extrapulmonary tuberculosis (EPTB) cases in immunocompetent hosts. Approximately 70% to 80% of CNS-TB cases present as TBM. [8]", "contents": "CNS Tuberculosis -- Epidemiology. Around\u00a025% to 30% of the human population is infected with MTB. CNS-TB is reported in 1% to 2% of individuals with active tuberculosis. [7] CNS-TB accounts for 5% to 8% of extrapulmonary tuberculosis (EPTB) cases in immunocompetent hosts. Approximately 70% to 80% of CNS-TB cases present as TBM. [8]"}
{"id": "article-135305_13", "title": "CNS Tuberculosis -- Epidemiology", "content": "Tuberculomas are seen mostly in India and parts of Asia and may account for 20% to 30% of all intracranial space-occupying lesions. [9] An estimated 9,272 CNS-TB cases were diagnosed in the U.S. in 2016. [10] Since 2010,\u00a0the incidence of tuberculosis has fallen by 2% to 3% every year, especially in 2020, probably due to the pandemic mitigation efforts, travel restrictions, or delayed or missed tuberculosis diagnoses. [11] However, the incidence of reported\u00a0tuberculosis rose\u00a0by 9.4% between 2020 and 2021. [12] Despite the diagnostic and treatment advances, CNS\u2013TB still carries\u00a0a mortality rate of 15% to 40%, especially in children. [13]", "contents": "CNS Tuberculosis -- Epidemiology. Tuberculomas are seen mostly in India and parts of Asia and may account for 20% to 30% of all intracranial space-occupying lesions. [9] An estimated 9,272 CNS-TB cases were diagnosed in the U.S. in 2016. [10] Since 2010,\u00a0the incidence of tuberculosis has fallen by 2% to 3% every year, especially in 2020, probably due to the pandemic mitigation efforts, travel restrictions, or delayed or missed tuberculosis diagnoses. [11] However, the incidence of reported\u00a0tuberculosis rose\u00a0by 9.4% between 2020 and 2021. [12] Despite the diagnostic and treatment advances, CNS\u2013TB still carries\u00a0a mortality rate of 15% to 40%, especially in children. [13]"}
{"id": "article-135305_14", "title": "CNS Tuberculosis -- Pathophysiology", "content": "The 3 CNS-TB forms develop by different mechanisms. Understanding\u00a0each condition's pathophysiology, explained below, is key to diagnosis.", "contents": "CNS Tuberculosis -- Pathophysiology. The 3 CNS-TB forms develop by different mechanisms. Understanding\u00a0each condition's pathophysiology, explained below, is key to diagnosis."}
{"id": "article-135305_15", "title": "CNS Tuberculosis -- Pathophysiology -- Tuberculous Meningitis", "content": "CNS-TB may arise from\u00a0hematogenous MTB dissemination following a primary lung infection (pulmonary tuberculosis or PTB) or late disease reactivation. [14] Meningeal or ependymal seeding results from this spread,\u00a0forming\u00a0multiple small granulomatous foci or tubercles (Rich foci) that may proliferate, coalesce, caseate, and rupture into the subarachnoid space before the onset of meningitis.\u00a0Free\u00a0bacilli produce an intense, cytokine-mediated host inflammatory response, leading to the following: Leptomeningitis, ependymitis, choroid plexitis, encephalitis, and pachymeningitis with basal and opticochiasmatic arachnoiditis (OCA) Vasculitis with endarteritis and infarcts Hydrocephalus secondary to disturbed CSF flow and absorption", "contents": "CNS Tuberculosis -- Pathophysiology -- Tuberculous Meningitis. CNS-TB may arise from\u00a0hematogenous MTB dissemination following a primary lung infection (pulmonary tuberculosis or PTB) or late disease reactivation. [14] Meningeal or ependymal seeding results from this spread,\u00a0forming\u00a0multiple small granulomatous foci or tubercles (Rich foci) that may proliferate, coalesce, caseate, and rupture into the subarachnoid space before the onset of meningitis.\u00a0Free\u00a0bacilli produce an intense, cytokine-mediated host inflammatory response, leading to the following: Leptomeningitis, ependymitis, choroid plexitis, encephalitis, and pachymeningitis with basal and opticochiasmatic arachnoiditis (OCA) Vasculitis with endarteritis and infarcts Hydrocephalus secondary to disturbed CSF flow and absorption"}
{"id": "article-135305_16", "title": "CNS Tuberculosis -- Pathophysiology -- Tuberculous Meningitis", "content": "The extensive exudative arachnoiditis at the brain's base and the optic chiasma\u00a0entraps multiple CNs in the area,\u00a0including the abducens, optic, oculomotor, and trochlear. Arteritis and phlebitis result in vasculitic infarcts due to arterial vasospasm, thrombosis, or hemorrhage. [15] The disparate inflammatory response in individuals with TBM is thought to be due to\u00a0human genetic polymorphisms in the leukotriene A4 hydrolase gene and toll-interleukin-1 receptor domain. [16]", "contents": "CNS Tuberculosis -- Pathophysiology -- Tuberculous Meningitis. The extensive exudative arachnoiditis at the brain's base and the optic chiasma\u00a0entraps multiple CNs in the area,\u00a0including the abducens, optic, oculomotor, and trochlear. Arteritis and phlebitis result in vasculitic infarcts due to arterial vasospasm, thrombosis, or hemorrhage. [15] The disparate inflammatory response in individuals with TBM is thought to be due to\u00a0human genetic polymorphisms in the leukotriene A4 hydrolase gene and toll-interleukin-1 receptor domain. [16]"}
{"id": "article-135305_17", "title": "CNS Tuberculosis -- Pathophysiology -- Tuberculous Meningitis", "content": "Inflammation can spread to the basal cisterns\u00a0in many patients symptomatic for\u00a0at least\u00a03\u00a0weeks, disrupting CSF circulation and absorption and producing communicating hydrocephalus [17] Obstructive\u00a0hydrocephalus occurs, though rarely, due to ependymitis-induced narrowing of the cerebral aqueduct or compression by brainstem tuberculoma in the 4th ventricle.", "contents": "CNS Tuberculosis -- Pathophysiology -- Tuberculous Meningitis. Inflammation can spread to the basal cisterns\u00a0in many patients symptomatic for\u00a0at least\u00a03\u00a0weeks, disrupting CSF circulation and absorption and producing communicating hydrocephalus [17] Obstructive\u00a0hydrocephalus occurs, though rarely, due to ependymitis-induced narrowing of the cerebral aqueduct or compression by brainstem tuberculoma in the 4th ventricle."}
{"id": "article-135305_18", "title": "CNS Tuberculosis -- Pathophysiology -- Tuberculoma", "content": "Deep-seated tubercular granulomatous foci acquired during initial bacteremia may coalesce and develop into conglomerated caseous masses called \"tuberculomas\" without producing meningitis. Often, tuberculomas may be present as clinically silent single or multiple lesions in patients with TBM and detected on brain imaging.\u00a0Tuberculomas may form tubercular abscesses in immunosuppressed individuals. Spinal cord tuberculoma may\u00a0form\u00a0at any cord level\u00a0through\u00a0similar\u00a0mechanisms\u00a0or by local extension from\u00a0nearby\u00a0tubercular spondylitis.", "contents": "CNS Tuberculosis -- Pathophysiology -- Tuberculoma. Deep-seated tubercular granulomatous foci acquired during initial bacteremia may coalesce and develop into conglomerated caseous masses called \"tuberculomas\" without producing meningitis. Often, tuberculomas may be present as clinically silent single or multiple lesions in patients with TBM and detected on brain imaging.\u00a0Tuberculomas may form tubercular abscesses in immunosuppressed individuals. Spinal cord tuberculoma may\u00a0form\u00a0at any cord level\u00a0through\u00a0similar\u00a0mechanisms\u00a0or by local extension from\u00a0nearby\u00a0tubercular spondylitis."}
{"id": "article-135305_19", "title": "CNS Tuberculosis -- Pathophysiology -- Spinal Arachnoiditis", "content": "Spinal arachnoiditis may arise as a result of previous TBM or vertebral osteomyelitis. The caseating inflammation may progress over weeks to months, leading to nerve root clumping or cord encasement (partial/total) by the thick gelatinous exudate or fibrous mass.", "contents": "CNS Tuberculosis -- Pathophysiology -- Spinal Arachnoiditis. Spinal arachnoiditis may arise as a result of previous TBM or vertebral osteomyelitis. The caseating inflammation may progress over weeks to months, leading to nerve root clumping or cord encasement (partial/total) by the thick gelatinous exudate or fibrous mass."}
{"id": "article-135305_20", "title": "CNS Tuberculosis -- Histopathology", "content": "Histologically, the thick inflammatory meningeal exudate is granulomatous, with epithelioid macrophages, Langhans' giant cells, lymphocytes, plasma cells, and fibroblasts (see Image . Tuberculous\u00a0Meningitis Histopathology). Tuberculomas are bigger encapsulated epithelioid granulomas with similar pleocytosis arranged in layers but a necrotic caseous center\u00a0without\u00a0pus. A tuberculous abscess has a thick wall with a liquefied pus core containing viable MTB bacilli.", "contents": "CNS Tuberculosis -- Histopathology. Histologically, the thick inflammatory meningeal exudate is granulomatous, with epithelioid macrophages, Langhans' giant cells, lymphocytes, plasma cells, and fibroblasts (see Image . Tuberculous\u00a0Meningitis Histopathology). Tuberculomas are bigger encapsulated epithelioid granulomas with similar pleocytosis arranged in layers but a necrotic caseous center\u00a0without\u00a0pus. A tuberculous abscess has a thick wall with a liquefied pus core containing viable MTB bacilli."}
{"id": "article-135305_21", "title": "CNS Tuberculosis -- History and Physical", "content": "The different CNS-TB forms produce various manifestations. The historical and physical features of each type are explained below.", "contents": "CNS Tuberculosis -- History and Physical. The different CNS-TB forms produce various manifestations. The historical and physical features of each type are explained below."}
{"id": "article-135305_22", "title": "CNS Tuberculosis -- History and Physical -- Tuberculous Meningitis", "content": "Patients with TBM often\u00a0present with a\u00a0subacute, progressive febrile illness beginning with a prodrome of constitutional\u00a0symptoms, including lassitude, malaise, night sweats, and intermittent headaches.\u00a0A well-defined meningitic phase is observed in the following fortnight or more. This phase includes protracted headaches, vomiting, personality changes, confusion, and meningismus symptoms. Patients with TBM may deteriorate rapidly, developing varying degrees of confusion and coma. Seizures, multiple CN deficits, focal neurological impairments, and stroke syndromes may supervene.", "contents": "CNS Tuberculosis -- History and Physical -- Tuberculous Meningitis. Patients with TBM often\u00a0present with a\u00a0subacute, progressive febrile illness beginning with a prodrome of constitutional\u00a0symptoms, including lassitude, malaise, night sweats, and intermittent headaches.\u00a0A well-defined meningitic phase is observed in the following fortnight or more. This phase includes protracted headaches, vomiting, personality changes, confusion, and meningismus symptoms. Patients with TBM may deteriorate rapidly, developing varying degrees of confusion and coma. Seizures, multiple CN deficits, focal neurological impairments, and stroke syndromes may supervene."}
{"id": "article-135305_23", "title": "CNS Tuberculosis -- History and Physical -- Tuberculous Meningitis", "content": "Children may have prominent irritability, vomiting, and focal or generalized convulsions. Individuals with untreated TBM may not survive beyond 5\u00a0to 8 weeks of illness. CN palsies are seen in 20% to 30% of patients with TBM, mostly involving CN VI. [18] OCA with blindness is a significant TBM complication. [19]", "contents": "CNS Tuberculosis -- History and Physical -- Tuberculous Meningitis. Children may have prominent irritability, vomiting, and focal or generalized convulsions. Individuals with untreated TBM may not survive beyond 5\u00a0to 8 weeks of illness. CN palsies are seen in 20% to 30% of patients with TBM, mostly involving CN VI. [18] OCA with blindness is a significant TBM complication. [19]"}
{"id": "article-135305_24", "title": "CNS Tuberculosis -- History and Physical -- Tuberculoma", "content": "This CNS-TB manifestation should be included in the differential diagnosis of space-occupying lesions in young individuals. The usual\u00a0symptoms include headaches, seizures, progressive neurological deficits, and papilledema with or without meningitis.", "contents": "CNS Tuberculosis -- History and Physical -- Tuberculoma. This CNS-TB manifestation should be included in the differential diagnosis of space-occupying lesions in young individuals. The usual\u00a0symptoms include headaches, seizures, progressive neurological deficits, and papilledema with or without meningitis."}
{"id": "article-135305_25", "title": "CNS Tuberculosis -- History and Physical -- Spinal Arachnoiditis", "content": "Individuals with this condition\u00a0present with radiculomyelopathy secondary to nerve root entrapment and cord encasement due to severe arachnoiditis at single or multiple levels. Patients may complain of radicular pain, hyperesthesia, flaccid paralysis, and urinary or stool incontinence. Cord infarction may occur due to\u00a0anterior spinal\u00a0arteritis and thrombosis (see Image. Pott Spine).", "contents": "CNS Tuberculosis -- History and Physical -- Spinal Arachnoiditis. Individuals with this condition\u00a0present with radiculomyelopathy secondary to nerve root entrapment and cord encasement due to severe arachnoiditis at single or multiple levels. Patients may complain of radicular pain, hyperesthesia, flaccid paralysis, and urinary or stool incontinence. Cord infarction may occur due to\u00a0anterior spinal\u00a0arteritis and thrombosis (see Image. Pott Spine)."}
{"id": "article-135305_26", "title": "CNS Tuberculosis -- History and Physical -- Atypical Presentations", "content": "CNS-TB\u00a0may manifest\u00a0in 10% to 30% of adult patients with\u00a0miliary tuberculosis. The condition arises from hematogenous MTB dissemination, with immunocompromised patients being the most vulnerable.\u00a0The\u00a0brain parenchyma may show multiple scattered tiny granulomatous foci, which may or may not show ring enhancement. [20]", "contents": "CNS Tuberculosis -- History and Physical -- Atypical Presentations. CNS-TB\u00a0may manifest\u00a0in 10% to 30% of adult patients with\u00a0miliary tuberculosis. The condition arises from hematogenous MTB dissemination, with immunocompromised patients being the most vulnerable.\u00a0The\u00a0brain parenchyma may show multiple scattered tiny granulomatous foci, which may or may not show ring enhancement. [20]"}
{"id": "article-135305_27", "title": "CNS Tuberculosis -- History and Physical -- Atypical Presentations", "content": "TBM may also manifest as progressive cognitive dysfunction or psychosis in rare cases.\u00a0The condition may\u00a0likewise mimic acute encephalitis or typical pyogenic meningitis.\u00a0Atypical cases\u00a0may present with florid cranial polyneuropathy or hydrocephalus complications that precede meningitis signs. [21]", "contents": "CNS Tuberculosis -- History and Physical -- Atypical Presentations. TBM may also manifest as progressive cognitive dysfunction or psychosis in rare cases.\u00a0The condition may\u00a0likewise mimic acute encephalitis or typical pyogenic meningitis.\u00a0Atypical cases\u00a0may present with florid cranial polyneuropathy or hydrocephalus complications that precede meningitis signs. [21]"}
{"id": "article-135305_28", "title": "CNS Tuberculosis -- History and Physical -- Tuberculous Meningitis and HIV Infection", "content": "HIV coinfection does not affect CNS-TB's clinical manifestations, CSF picture, or prognosis. However, HIV-seropositive TBM may have a normal CSF,\u00a0with\u00a0radiographic clues holding greater importance in such cases.\u00a0Cryptococcal meningitis is a close differential diagnosis and may sometimes occur concurrently. Intracerebral tuberculomas are more likely to occur in HIV patients than in the general population, often as multiloculated tubercular abscesses. CNS lymphoma or toxoplasma encephalitis closely mimics the condition.\u00a0However,\u00a0cisternal enhancement, basal ganglia infarction, and communicating hydrocephalus favor\u00a0a\u00a0CNS-TB diagnosis. [22]", "contents": "CNS Tuberculosis -- History and Physical -- Tuberculous Meningitis and HIV Infection. HIV coinfection does not affect CNS-TB's clinical manifestations, CSF picture, or prognosis. However, HIV-seropositive TBM may have a normal CSF,\u00a0with\u00a0radiographic clues holding greater importance in such cases.\u00a0Cryptococcal meningitis is a close differential diagnosis and may sometimes occur concurrently. Intracerebral tuberculomas are more likely to occur in HIV patients than in the general population, often as multiloculated tubercular abscesses. CNS lymphoma or toxoplasma encephalitis closely mimics the condition.\u00a0However,\u00a0cisternal enhancement, basal ganglia infarction, and communicating hydrocephalus favor\u00a0a\u00a0CNS-TB diagnosis. [22]"}
{"id": "article-135305_29", "title": "CNS Tuberculosis -- Evaluation -- Clinical Diagnosis of Tuberculous Meningitis", "content": "CNS-TB is a paucibacillary disease, often eluding definitive diagnosis. [23] Conventional diagnostic techniques are insensitive and laborious. [24] Clinical scoring algorithms for definitive CNS-TB diagnosis are flawed and unreliable. [25] [26] With early and precise identification\u00a0being crucial for survival, diagnosis typically relies on a combination of evidence from patient history, neurological examination, CSF analysis, and radiological imaging. [27]", "contents": "CNS Tuberculosis -- Evaluation -- Clinical Diagnosis of Tuberculous Meningitis. CNS-TB is a paucibacillary disease, often eluding definitive diagnosis. [23] Conventional diagnostic techniques are insensitive and laborious. [24] Clinical scoring algorithms for definitive CNS-TB diagnosis are flawed and unreliable. [25] [26] With early and precise identification\u00a0being crucial for survival, diagnosis typically relies on a combination of evidence from patient history, neurological examination, CSF analysis, and radiological imaging. [27]"}
{"id": "article-135305_30", "title": "CNS Tuberculosis -- Evaluation -- Clinical Diagnosis of Tuberculous Meningitis", "content": "Newer molecular techniques help confirm\u00a0the presence of MTB in CSF, which is often\u00a0challenging.\u00a0Still, a definitive diagnosis\u00a0is not always achievable, necessitating presumptive and prompt treatment initiation to mitigate delay-related risks. Investigating epidemiological factors and personal risk variables is crucial, even though such data may be limited in adults. Notably, active\u00a0tuberculosis exposure can be identified in 70% to 90% of\u00a0children with TBM.", "contents": "CNS Tuberculosis -- Evaluation -- Clinical Diagnosis of Tuberculous Meningitis. Newer molecular techniques help confirm\u00a0the presence of MTB in CSF, which is often\u00a0challenging.\u00a0Still, a definitive diagnosis\u00a0is not always achievable, necessitating presumptive and prompt treatment initiation to mitigate delay-related risks. Investigating epidemiological factors and personal risk variables is crucial, even though such data may be limited in adults. Notably, active\u00a0tuberculosis exposure can be identified in 70% to 90% of\u00a0children with TBM."}
{"id": "article-135305_31", "title": "CNS Tuberculosis -- Evaluation -- Clinical Diagnosis of Tuberculous Meningitis", "content": "Identifying active extraneural infection\u00a0occasionally\u00a0aids in determining a presumptive diagnosis. Chest radiographs\u00a0are beneficial in\u00a0most pediatric TBM cases and approximately 50% of adult cases (see Image . Pulmonary Tuberculosis). Laboratory analysis may indicate mild anemia, lymphocytosis, and hyponatremia. A positive tuberculin test offers supportive evidence, notably in children, though a negative result does not rule out the diagnosis.\u00a0Funduscopy\u00a0may also uncover papilledema and choroid tubercles, aiding diagnosis (see Image .\u00a0Tuberculoma on Funduscopy). [28]", "contents": "CNS Tuberculosis -- Evaluation -- Clinical Diagnosis of Tuberculous Meningitis. Identifying active extraneural infection\u00a0occasionally\u00a0aids in determining a presumptive diagnosis. Chest radiographs\u00a0are beneficial in\u00a0most pediatric TBM cases and approximately 50% of adult cases (see Image . Pulmonary Tuberculosis). Laboratory analysis may indicate mild anemia, lymphocytosis, and hyponatremia. A positive tuberculin test offers supportive evidence, notably in children, though a negative result does not rule out the diagnosis.\u00a0Funduscopy\u00a0may also uncover papilledema and choroid tubercles, aiding diagnosis (see Image .\u00a0Tuberculoma on Funduscopy). [28]"}
{"id": "article-135305_32", "title": "CNS Tuberculosis -- Evaluation -- Cerebrospinal Fluid Examination and Culture", "content": "A pellicle or cobweb may form during gross CSF examination, which is representative but not pathognomonic of TBM. A xanthochromic CSF indicates\u00a0unusually high protein content. CSF cytological analysis typically shows the total cell count between 100 and 500/mm3 in the majority.\u00a0Less than 100 cells/mm3 are present in 15% of cases. Pleocytosis may be absent in people of advanced age or with miliary tuberculosis-related\u00a0CNS-TB\u00a0or HIV coinfection.", "contents": "CNS Tuberculosis -- Evaluation -- Cerebrospinal Fluid Examination and Culture. A pellicle or cobweb may form during gross CSF examination, which is representative but not pathognomonic of TBM. A xanthochromic CSF indicates\u00a0unusually high protein content. CSF cytological analysis typically shows the total cell count between 100 and 500/mm3 in the majority.\u00a0Less than 100 cells/mm3 are present in 15% of cases. Pleocytosis may be absent in people of advanced age or with miliary tuberculosis-related\u00a0CNS-TB\u00a0or HIV coinfection."}
{"id": "article-135305_33", "title": "CNS Tuberculosis -- Evaluation -- Cerebrospinal Fluid Examination and Culture", "content": "The CSF cell number may be 500\u00a0to 1,500 cells/mm3 in 20% of cases. A transient polymorphonuclear predominance or mixed pleocytosis may also be observed\u00a0in the first week of illness. However,\u00a0predominant lymphomononuclear pleocytosis is the typical CSF\u00a0finding in TBM. CSF protein concentration varies from 100\u00a0to 500 mg/dl. About 25% of cases may have less than 100 mg/dl of protein, and 10% may have greater than 500 mg/dl. Values exceeding\u00a01\u00a0g/dl\u00a0is\u00a0characteristic of severe adhesive spinal arachnoiditis and portends a poor prognosis. The CSF glucose level is less than 45 mg/dl in 80% of cases.\u00a0However, unlike acute pyogenic meningitis, CSF glucose is never undetectable.", "contents": "CNS Tuberculosis -- Evaluation -- Cerebrospinal Fluid Examination and Culture. The CSF cell number may be 500\u00a0to 1,500 cells/mm3 in 20% of cases. A transient polymorphonuclear predominance or mixed pleocytosis may also be observed\u00a0in the first week of illness. However,\u00a0predominant lymphomononuclear pleocytosis is the typical CSF\u00a0finding in TBM. CSF protein concentration varies from 100\u00a0to 500 mg/dl. About 25% of cases may have less than 100 mg/dl of protein, and 10% may have greater than 500 mg/dl. Values exceeding\u00a01\u00a0g/dl\u00a0is\u00a0characteristic of severe adhesive spinal arachnoiditis and portends a poor prognosis. The CSF glucose level is less than 45 mg/dl in 80% of cases.\u00a0However, unlike acute pyogenic meningitis, CSF glucose is never undetectable."}
{"id": "article-135305_34", "title": "CNS Tuberculosis -- Evaluation -- Microbiological Tests", "content": "Demonstrating MTB in the CSF smear using Ziehl-Neelsen and auramine-rhodamine staining is crucial but elusive. The detection rates range from 12.5% to 69%, showing significant variability across reports. Traditional Lowenstein-Jensen culture takes\u00a04 to 8 weeks for growth reporting but detects MTB only in 25% to 70% of cases. Liquid culture media like Septi-Chek/Middlebrook 7H9 enhance detection rates.\u00a0Detection often\u00a0improves\u00a0with larger sample volumes, more CSF\u00a0specimens, centrifugation, and preparing thick smears from the pellicle. [29]", "contents": "CNS Tuberculosis -- Evaluation -- Microbiological Tests. Demonstrating MTB in the CSF smear using Ziehl-Neelsen and auramine-rhodamine staining is crucial but elusive. The detection rates range from 12.5% to 69%, showing significant variability across reports. Traditional Lowenstein-Jensen culture takes\u00a04 to 8 weeks for growth reporting but detects MTB only in 25% to 70% of cases. Liquid culture media like Septi-Chek/Middlebrook 7H9 enhance detection rates.\u00a0Detection often\u00a0improves\u00a0with larger sample volumes, more CSF\u00a0specimens, centrifugation, and preparing thick smears from the pellicle. [29]"}
{"id": "article-135305_35", "title": "CNS Tuberculosis -- Evaluation -- Molecular Diagnostic Techniques", "content": "The World Health Organization recommends Xpert MTB/rifampin (Xpert MTB/RIF), a polymerase chain reaction technique,\u00a0to be used for molecular TBM diagnosis in CSF specimens, particularly in situations with limited sample volume. [30] [31] This quick and automated cartridge-based nucleic acid amplification test targets\u00a0MTB's rpob gene, enabling simultaneous detection of MTB and rifampin resistance. [32] An Xpert MTB/RIF meta-analysis demonstrated a sensitivity of 80.5% and a specificity of 97.8%. [33] Loop-mediated isothermal amplification assay is another promising, rapid, and cost-effective technique in resource-limited regions. [34]", "contents": "CNS Tuberculosis -- Evaluation -- Molecular Diagnostic Techniques. The World Health Organization recommends Xpert MTB/rifampin (Xpert MTB/RIF), a polymerase chain reaction technique,\u00a0to be used for molecular TBM diagnosis in CSF specimens, particularly in situations with limited sample volume. [30] [31] This quick and automated cartridge-based nucleic acid amplification test targets\u00a0MTB's rpob gene, enabling simultaneous detection of MTB and rifampin resistance. [32] An Xpert MTB/RIF meta-analysis demonstrated a sensitivity of 80.5% and a specificity of 97.8%. [33] Loop-mediated isothermal amplification assay is another promising, rapid, and cost-effective technique in resource-limited regions. [34]"}
{"id": "article-135305_36", "title": "CNS Tuberculosis -- Evaluation -- Molecular Diagnostic Techniques", "content": "CSF assays for the\u00a0MTB cell wall glycolipid lipoarabinomannan show sensitivity comparable to Xpert MTB/RIF, potentially aiding TBM diagnosis in patients with HIV, particularly in resource-limited settings. [35] Lipoarabinomannan detection in CSF demonstrates high TBM specificity. [36] CSF interferon-\u03b3 release assays have superior diagnostic accuracy\u00a0over\u00a0blood\u00a0interferon-\u03b3 release assays\u00a0in evaluating TBM. [37] [38]", "contents": "CNS Tuberculosis -- Evaluation -- Molecular Diagnostic Techniques. CSF assays for the\u00a0MTB cell wall glycolipid lipoarabinomannan show sensitivity comparable to Xpert MTB/RIF, potentially aiding TBM diagnosis in patients with HIV, particularly in resource-limited settings. [35] Lipoarabinomannan detection in CSF demonstrates high TBM specificity. [36] CSF interferon-\u03b3 release assays have superior diagnostic accuracy\u00a0over\u00a0blood\u00a0interferon-\u03b3 release assays\u00a0in evaluating TBM. [37] [38]"}
{"id": "article-135305_37", "title": "CNS Tuberculosis -- Evaluation -- Molecular Diagnostic Techniques", "content": "Metagenomic next-generation sequencing (mNGS) has recently been shown to provide rapid and sensitive diagnostic capability in TBM. [39] [40] Adding mNGS to CSF analysis may\u00a0prove to\u00a0be a valuable diagnostic tool\u00a0when combined with traditional diagnostic methods.", "contents": "CNS Tuberculosis -- Evaluation -- Molecular Diagnostic Techniques. Metagenomic next-generation sequencing (mNGS) has recently been shown to provide rapid and sensitive diagnostic capability in TBM. [39] [40] Adding mNGS to CSF analysis may\u00a0prove to\u00a0be a valuable diagnostic tool\u00a0when combined with traditional diagnostic methods."}
{"id": "article-135305_38", "title": "CNS Tuberculosis -- Evaluation -- Adenosine Deaminase", "content": "Adenosine deaminase (ADA) is an enzyme produced by T-lymphocytes\u00a0that\u00a0serves as an indirect measure of\u00a0the host response to MTB and\u00a0holds significant diagnostic value.\u00a0Elevated ADA levels are observed in the CSF of 60% to 100% of individuals with TBM, with a cutoff value of 9.5 U/L used to distinguish TBM from non-TBM cases. Dynamic CSF-ADA activity monitoring may provide further diagnostic assistance. [41] One study\u00a0demonstrates that ADA measurement has a sensitivity of 92.5% and a specificity of 97%, with the cutoff set\u00a0to\u00a010 U/L. [42]", "contents": "CNS Tuberculosis -- Evaluation -- Adenosine Deaminase. Adenosine deaminase (ADA) is an enzyme produced by T-lymphocytes\u00a0that\u00a0serves as an indirect measure of\u00a0the host response to MTB and\u00a0holds significant diagnostic value.\u00a0Elevated ADA levels are observed in the CSF of 60% to 100% of individuals with TBM, with a cutoff value of 9.5 U/L used to distinguish TBM from non-TBM cases. Dynamic CSF-ADA activity monitoring may provide further diagnostic assistance. [41] One study\u00a0demonstrates that ADA measurement has a sensitivity of 92.5% and a specificity of 97%, with the cutoff set\u00a0to\u00a010 U/L. [42]"}
{"id": "article-135305_39", "title": "CNS Tuberculosis -- Evaluation -- Imaging", "content": "Neuroimaging is vital in diagnosing\u00a0suspected CNS-TB\u00a0cases,\u00a0helping ensure a timely and correct diagnosis. Neuroimaging ideally must include the entire neuroaxis. The evaluation modalities include brain computed tomography (CT) or magnetic resonance imaging, with contrast-enhanced MRI having a superior delineating ability.\u00a0Newer techniques further enhance\u00a0MRI's\u00a0diagnostic\u00a0reliability\u00a0in atypical or difficult cases (see Image . Tuberculous\u00a0Meningitis on Magnetic Resonance Imaging). [43] The diagnostic triad of TBM consists of the following: Extensive basilar leptomeningeal enhancement and\u00a0exudates,\u00a0found\u00a0in 38% to 89% Hydrocephalus, detected in 60% to 75% Cerebral\u00a0infarcts,\u00a0seen\u00a0in 15% to 28%, followed by tuberculoma in another 27% of cases [44] [45] [46]", "contents": "CNS Tuberculosis -- Evaluation -- Imaging. Neuroimaging is vital in diagnosing\u00a0suspected CNS-TB\u00a0cases,\u00a0helping ensure a timely and correct diagnosis. Neuroimaging ideally must include the entire neuroaxis. The evaluation modalities include brain computed tomography (CT) or magnetic resonance imaging, with contrast-enhanced MRI having a superior delineating ability.\u00a0Newer techniques further enhance\u00a0MRI's\u00a0diagnostic\u00a0reliability\u00a0in atypical or difficult cases (see Image . Tuberculous\u00a0Meningitis on Magnetic Resonance Imaging). [43] The diagnostic triad of TBM consists of the following: Extensive basilar leptomeningeal enhancement and\u00a0exudates,\u00a0found\u00a0in 38% to 89% Hydrocephalus, detected in 60% to 75% Cerebral\u00a0infarcts,\u00a0seen\u00a0in 15% to 28%, followed by tuberculoma in another 27% of cases [44] [45] [46]"}
{"id": "article-135305_40", "title": "CNS Tuberculosis -- Evaluation -- Imaging", "content": "TBM\u00a0exudates have certain areas of predilection. Optochiasmatic arachnoiditis is almost pathognomonic\u00a0of TBM. [47] The other areas include the interpeduncular fossa,\u00a0perimesencephalic\u00a0region, cisterna\u00a0ambiens, and suprasellar and Sylvian cisterns. Exudates are best discerned on MRI\u00a0fluid-attenuated inversion recovery\u00a0sequences, while enhanced meninges are\u00a0more visible on postcontrast spin echo MRI (see Image. Tuberculous Meningitis on MRI).", "contents": "CNS Tuberculosis -- Evaluation -- Imaging. TBM\u00a0exudates have certain areas of predilection. Optochiasmatic arachnoiditis is almost pathognomonic\u00a0of TBM. [47] The other areas include the interpeduncular fossa,\u00a0perimesencephalic\u00a0region, cisterna\u00a0ambiens, and suprasellar and Sylvian cisterns. Exudates are best discerned on MRI\u00a0fluid-attenuated inversion recovery\u00a0sequences, while enhanced meninges are\u00a0more visible on postcontrast spin echo MRI (see Image. Tuberculous Meningitis on MRI)."}
{"id": "article-135305_41", "title": "CNS Tuberculosis -- Evaluation -- Imaging", "content": "On CT, intense basal cisternal enhancement may appear as a characteristic spider leg appearance\u00a0(see Image .\u00a0Tuberculous\u00a0Meningitis on Computed Tomography). [48] Imaging features are specific (95\u2013100%) for TBM only when\u00a0interpreted\u00a0in combination.\u00a0However,\u00a0these findings\u00a0have reduced\u00a0sensitivity if taken individually.", "contents": "CNS Tuberculosis -- Evaluation -- Imaging. On CT, intense basal cisternal enhancement may appear as a characteristic spider leg appearance\u00a0(see Image .\u00a0Tuberculous\u00a0Meningitis on Computed Tomography). [48] Imaging features are specific (95\u2013100%) for TBM only when\u00a0interpreted\u00a0in combination.\u00a0However,\u00a0these findings\u00a0have reduced\u00a0sensitivity if taken individually."}
{"id": "article-135305_42", "title": "CNS Tuberculosis -- Evaluation -- Imaging", "content": "TBM's\u00a0basal pachymeningitis involves mostly the middle cerebral artery's M1 segment, circle of Willis, and lenticulostriate and thalamus-perforating arteries, causing a stroke. [49] The vasculitic infarcts are usually bilateral and multiple, mostly affecting the periventricular area, basal nuclei, and internal capsule. Magnetic resonance\u00a0angiography helps delineate vascular narrowing in cerebral infarction territories. [50] Diffusion-weighted imaging is an advanced MRI technique that accurately\u00a0identifies TBM-related cerebral vasculitis and varying stroke stages. [51]", "contents": "CNS Tuberculosis -- Evaluation -- Imaging. TBM's\u00a0basal pachymeningitis involves mostly the middle cerebral artery's M1 segment, circle of Willis, and lenticulostriate and thalamus-perforating arteries, causing a stroke. [49] The vasculitic infarcts are usually bilateral and multiple, mostly affecting the periventricular area, basal nuclei, and internal capsule. Magnetic resonance\u00a0angiography helps delineate vascular narrowing in cerebral infarction territories. [50] Diffusion-weighted imaging is an advanced MRI technique that accurately\u00a0identifies TBM-related cerebral vasculitis and varying stroke stages. [51]"}
{"id": "article-135305_43", "title": "CNS Tuberculosis -- Evaluation -- Imaging", "content": "Tuberculomas are visible as discrete, single, or numerous ring-enhancing lesions with marked perilesional\u00a0edema\u00a0commonly located at the corticomedullary junction. (see Image. Brain Tuberculoma on MRI).\u00a0Tuberculomas\u00a0may\u00a0appear differently on CT scans\u00a0depending on their maturation stage, presenting as either noncaseating or solidly caseating lesions.\u00a0CT may also demonstrate caseating masses with central liquefication or calcification (target sign). [52] [53]", "contents": "CNS Tuberculosis -- Evaluation -- Imaging. Tuberculomas are visible as discrete, single, or numerous ring-enhancing lesions with marked perilesional\u00a0edema\u00a0commonly located at the corticomedullary junction. (see Image. Brain Tuberculoma on MRI).\u00a0Tuberculomas\u00a0may\u00a0appear differently on CT scans\u00a0depending on their maturation stage, presenting as either noncaseating or solidly caseating lesions.\u00a0CT may also demonstrate caseating masses with central liquefication or calcification (target sign). [52] [53]"}
{"id": "article-135305_44", "title": "CNS Tuberculosis -- Evaluation -- Imaging", "content": "MRI\u00a0often shows\u00a0hypointensities\u00a0on T1W and hyperintensities\u00a0on T2W images. Postcontrast images delineate\u00a0either\u00a0ring-shaped or homogeneous disc-shaped enhancement (see Image . Brain Tuberculoma on Magnetic Resonance Imaging). Tuberculomas'\u00a0unique metabolite pattern on magnetic resonance spectroscopy may differentiate\u00a0them\u00a0from metastases and gliomas. A complete and regular peripheral hypointense ring in susceptibility-weighted imaging (SWI) favors the diagnosis of tuberculomas. [54]", "contents": "CNS Tuberculosis -- Evaluation -- Imaging. MRI\u00a0often shows\u00a0hypointensities\u00a0on T1W and hyperintensities\u00a0on T2W images. Postcontrast images delineate\u00a0either\u00a0ring-shaped or homogeneous disc-shaped enhancement (see Image . Brain Tuberculoma on Magnetic Resonance Imaging). Tuberculomas'\u00a0unique metabolite pattern on magnetic resonance spectroscopy may differentiate\u00a0them\u00a0from metastases and gliomas. A complete and regular peripheral hypointense ring in susceptibility-weighted imaging (SWI) favors the diagnosis of tuberculomas. [54]"}
{"id": "article-135305_45", "title": "CNS Tuberculosis -- Evaluation -- Imaging", "content": "Tuberculous myelitis may be visible as diffuse cord swelling with\u00a0an altered signal on MRI.\u00a0Phase-contrast MRI is the technique of choice for\u00a0identifying\u00a0spinal subarachnoid space obliteration, dural thickening, paraspinal exudates, cauda equina nerve root clumps, CSF loculations, cord infarction,\u00a0and\u00a0syringomyelia in spinal arachnoiditis. [55] [56]", "contents": "CNS Tuberculosis -- Evaluation -- Imaging. Tuberculous myelitis may be visible as diffuse cord swelling with\u00a0an altered signal on MRI.\u00a0Phase-contrast MRI is the technique of choice for\u00a0identifying\u00a0spinal subarachnoid space obliteration, dural thickening, paraspinal exudates, cauda equina nerve root clumps, CSF loculations, cord infarction,\u00a0and\u00a0syringomyelia in spinal arachnoiditis. [55] [56]"}
{"id": "article-135305_46", "title": "CNS Tuberculosis -- Treatment / Management", "content": "Considering\u00a0CNS-TB's high mortality and morbidity rates and various diagnostic challenges, empiric treatment with antituberculous therapy (ATT) and adjunctive corticosteroids may commence based on strong clinical suspicion.\u00a0Patients must be closely monitored for prompt\u00a0treatment of adverse drug reactions and disease-related complications. No randomized clinical trials can ascertain the most favorable drug combination, dosage, and duration for treating this condition. Various guidelines\u00a0recommend different treatment regimens. [57] [58] [59] [60] Drug susceptibility data (when available) and clinical response must always be considered regardless of the combination chosen. The optimal treatment duration is uncertain.", "contents": "CNS Tuberculosis -- Treatment / Management. Considering\u00a0CNS-TB's high mortality and morbidity rates and various diagnostic challenges, empiric treatment with antituberculous therapy (ATT) and adjunctive corticosteroids may commence based on strong clinical suspicion.\u00a0Patients must be closely monitored for prompt\u00a0treatment of adverse drug reactions and disease-related complications. No randomized clinical trials can ascertain the most favorable drug combination, dosage, and duration for treating this condition. Various guidelines\u00a0recommend different treatment regimens. [57] [58] [59] [60] Drug susceptibility data (when available) and clinical response must always be considered regardless of the combination chosen. The optimal treatment duration is uncertain."}
{"id": "article-135305_47", "title": "CNS Tuberculosis -- Treatment / Management -- Drug-Susceptible Central\u00a0Nervous System\u00a0Tuberculosis", "content": "The current guidelines\u00a0recommend\u00a04\u00a0orally administered drugs: isoniazid (INH) 5 mg/kg/d, rifampicin (RMP) 10 mg/kg/d, pyrazinamide (PZA) 25 mg/kg/d, and ethambutol (ETB) 15 mg/kg/d for the first\u00a02\u00a0months, constituting the intensive phase. The continuation phase includes\u00a0INH, RMP, and ETB daily for at least\u00a07\u00a0months. PZA and EMB may be discontinued in the maintenance phase. PZA omission\u00a0in the intensive phase\u00a0warrants extending\u00a0treatment to 18 months.\u00a0Directly observed therapy short-course, which involves thrice-weekly\u00a0drug administration, is currently not the standard of care\u00a0for CNS-TB in India.", "contents": "CNS Tuberculosis -- Treatment / Management -- Drug-Susceptible Central\u00a0Nervous System\u00a0Tuberculosis. The current guidelines\u00a0recommend\u00a04\u00a0orally administered drugs: isoniazid (INH) 5 mg/kg/d, rifampicin (RMP) 10 mg/kg/d, pyrazinamide (PZA) 25 mg/kg/d, and ethambutol (ETB) 15 mg/kg/d for the first\u00a02\u00a0months, constituting the intensive phase. The continuation phase includes\u00a0INH, RMP, and ETB daily for at least\u00a07\u00a0months. PZA and EMB may be discontinued in the maintenance phase. PZA omission\u00a0in the intensive phase\u00a0warrants extending\u00a0treatment to 18 months.\u00a0Directly observed therapy short-course, which involves thrice-weekly\u00a0drug administration, is currently not the standard of care\u00a0for CNS-TB in India."}
{"id": "article-135305_48", "title": "CNS Tuberculosis -- Treatment / Management -- Drug-Susceptible Central\u00a0Nervous System\u00a0Tuberculosis", "content": "INH displays early bactericidal activity.\u00a0RMP has excellent sterilizing activity, clearing persistent bacilli. PZA penetrates the\u00a0BBB readily. ETB is a weak drug but completes the regimen for drug-susceptible\u00a0tuberculosis.\u00a0Drugs\u00a0that\u00a0may\u00a0replace ETB\u00a0include streptomycin,\u00a0levofloxacin,\u00a0and\u00a0ethionamide. ETB is avoided when the patient's vision is compromised at baseline or cannot be assessed regularly. Streptomycin\u00a0is\u00a0contraindicated in\u00a0pregnancy, kidney impairment,\u00a0and hearing loss. Levofloxacin is superior to gatifloxacin or ciprofloxacin. [61] Higher RMP or levofloxacin doses are not associated with better survival. [62]", "contents": "CNS Tuberculosis -- Treatment / Management -- Drug-Susceptible Central\u00a0Nervous System\u00a0Tuberculosis. INH displays early bactericidal activity.\u00a0RMP has excellent sterilizing activity, clearing persistent bacilli. PZA penetrates the\u00a0BBB readily. ETB is a weak drug but completes the regimen for drug-susceptible\u00a0tuberculosis.\u00a0Drugs\u00a0that\u00a0may\u00a0replace ETB\u00a0include streptomycin,\u00a0levofloxacin,\u00a0and\u00a0ethionamide. ETB is avoided when the patient's vision is compromised at baseline or cannot be assessed regularly. Streptomycin\u00a0is\u00a0contraindicated in\u00a0pregnancy, kidney impairment,\u00a0and hearing loss. Levofloxacin is superior to gatifloxacin or ciprofloxacin. [61] Higher RMP or levofloxacin doses are not associated with better survival. [62]"}
{"id": "article-135305_49", "title": "CNS Tuberculosis -- Treatment / Management -- Drug-Susceptible Central\u00a0Nervous System\u00a0Tuberculosis", "content": "OCA management continues to be a challenge. The response is usually disappointing,\u00a0and pulse corticosteroids, thalidomide, and hyaluronidase have been tried with inconsistent outcomes. Neurosurgical intervention and its optimum timing are debatable. Paradoxical OCA also has a variable response. [63]", "contents": "CNS Tuberculosis -- Treatment / Management -- Drug-Susceptible Central\u00a0Nervous System\u00a0Tuberculosis. OCA management continues to be a challenge. The response is usually disappointing,\u00a0and pulse corticosteroids, thalidomide, and hyaluronidase have been tried with inconsistent outcomes. Neurosurgical intervention and its optimum timing are debatable. Paradoxical OCA also has a variable response. [63]"}
{"id": "article-135305_50", "title": "CNS Tuberculosis -- Treatment / Management -- Drug-Resistant\u00a0Central Nervous System\u00a0Tuberculosis", "content": "The guidelines for\u00a0managing drug-resistant CNS-TB are similar to those for PTB. The key principle involves never adding a single drug to a failing regimen. Management is challenging due to the huge number of drugs with overlapping\u00a0adverse drug reaction profiles. The newer agents, bedaquiline\u00a0and\u00a0delamanid, received accelerated approvals for PTB but not\u00a0CNS-TB. [64]", "contents": "CNS Tuberculosis -- Treatment / Management -- Drug-Resistant\u00a0Central Nervous System\u00a0Tuberculosis. The guidelines for\u00a0managing drug-resistant CNS-TB are similar to those for PTB. The key principle involves never adding a single drug to a failing regimen. Management is challenging due to the huge number of drugs with overlapping\u00a0adverse drug reaction profiles. The newer agents, bedaquiline\u00a0and\u00a0delamanid, received accelerated approvals for PTB but not\u00a0CNS-TB. [64]"}
{"id": "article-135305_51", "title": "CNS Tuberculosis -- Treatment / Management -- Tuberculomas", "content": "International guidelines recommend treating tuberculomas with standard ATT for CNS-TB for 9\u00a0to 12 months. [65] [66] Clinical improvement and radiological clearance are observed in 90% and 80% of patients, respectively, by\u00a09\u00a0months. Complete resolution depends upon the lesion's initial size.\u00a0Tuberculomas\u00a0smaller than 2.5\u00a0cm resolve in 5 to 8\u00a0months, while 50% of lesions larger than 2.5\u00a0cm take over 12\u00a0months to disappear. [67] Additionally, guidelines recommend that every patient should receive adjunctive steroids, especially in the presence of paradoxical responses. [68] Surgical intervention is indicated in patients unresponsive to medical management or\u00a0with raised intracranial pressure. [65]", "contents": "CNS Tuberculosis -- Treatment / Management -- Tuberculomas. International guidelines recommend treating tuberculomas with standard ATT for CNS-TB for 9\u00a0to 12 months. [65] [66] Clinical improvement and radiological clearance are observed in 90% and 80% of patients, respectively, by\u00a09\u00a0months. Complete resolution depends upon the lesion's initial size.\u00a0Tuberculomas\u00a0smaller than 2.5\u00a0cm resolve in 5 to 8\u00a0months, while 50% of lesions larger than 2.5\u00a0cm take over 12\u00a0months to disappear. [67] Additionally, guidelines recommend that every patient should receive adjunctive steroids, especially in the presence of paradoxical responses. [68] Surgical intervention is indicated in patients unresponsive to medical management or\u00a0with raised intracranial pressure. [65]"}
{"id": "article-135305_52", "title": "CNS Tuberculosis -- Treatment / Management -- Spinal Arachnoiditis", "content": "Spinal\u00a0tuberculosis is managed similarly to other EPTB forms.\u00a0Most international guidelines recommend daily therapy for 6 to 9 months, possibly extending to 24 months if the patient's response is unsatisfactory. [69] The conservative approach generally has functional outcomes similar to\u00a0those of\u00a0surgical treatment. Decompression surgery should be considered in\u00a0individuals with progressive IRIS-unrelated neurological deficits. [70] [71]", "contents": "CNS Tuberculosis -- Treatment / Management -- Spinal Arachnoiditis. Spinal\u00a0tuberculosis is managed similarly to other EPTB forms.\u00a0Most international guidelines recommend daily therapy for 6 to 9 months, possibly extending to 24 months if the patient's response is unsatisfactory. [69] The conservative approach generally has functional outcomes similar to\u00a0those of\u00a0surgical treatment. Decompression surgery should be considered in\u00a0individuals with progressive IRIS-unrelated neurological deficits. [70] [71]"}
{"id": "article-135305_53", "title": "CNS Tuberculosis -- Treatment / Management -- Anti-Inflammatory Drugs\u00a0and Supportive Therapy", "content": "The use of adjunctive steroid therapy in TBM management remains an area of ongoing debate. A recent meta-analysis identified clinical benefits when dexamethasone was combined with standard\u00a0ATT regimens\u00a0for treating TBM. [72] Few robust, prospective randomized control studies provide definitive data on adjunctive steroid therapy's efficacy in this setting. Thwaites\u00a0et al's\u00a0randomized study found that\u00a0adjunctive steroid therapy provided a survival benefit but did not prevent TBM-associated disability. [73]", "contents": "CNS Tuberculosis -- Treatment / Management -- Anti-Inflammatory Drugs\u00a0and Supportive Therapy. The use of adjunctive steroid therapy in TBM management remains an area of ongoing debate. A recent meta-analysis identified clinical benefits when dexamethasone was combined with standard\u00a0ATT regimens\u00a0for treating TBM. [72] Few robust, prospective randomized control studies provide definitive data on adjunctive steroid therapy's efficacy in this setting. Thwaites\u00a0et al's\u00a0randomized study found that\u00a0adjunctive steroid therapy provided a survival benefit but did not prevent TBM-associated disability. [73]"}
{"id": "article-135305_54", "title": "CNS Tuberculosis -- Treatment / Management -- Anti-Inflammatory Drugs\u00a0and Supportive Therapy", "content": "Donovan\u00a0et al's\u00a0recent, large randomized study found no survival benefit to\u00a0using adjunctive dexamethasone in TBM treatment in patients with HIV. [74] Steroids are generally recommended for all TBM stages, except in stage 1 (mild disease), where the clinician may use\u00a0their judgment.\u00a0Dexamethasone's daily dose is 0.6\u00a0mg/kg/d\u00a0in children and 0.4\u00a0mg/kg/d in adults. Prednisolone is an alternative used in doses of 2\u00a0to 4\u00a0mg/kg/d\u00a0in children and 2.5\u00a0mg/kg/d in adults for a minimum of 4 weeks, followed by gradual tapering over the next\u00a04\u00a0weeks. [75] Steroids have been shown to improve survival in TBM but probably do not prevent residual neurologic deficits and severe disability. [76]", "contents": "CNS Tuberculosis -- Treatment / Management -- Anti-Inflammatory Drugs\u00a0and Supportive Therapy. Donovan\u00a0et al's\u00a0recent, large randomized study found no survival benefit to\u00a0using adjunctive dexamethasone in TBM treatment in patients with HIV. [74] Steroids are generally recommended for all TBM stages, except in stage 1 (mild disease), where the clinician may use\u00a0their judgment.\u00a0Dexamethasone's daily dose is 0.6\u00a0mg/kg/d\u00a0in children and 0.4\u00a0mg/kg/d in adults. Prednisolone is an alternative used in doses of 2\u00a0to 4\u00a0mg/kg/d\u00a0in children and 2.5\u00a0mg/kg/d in adults for a minimum of 4 weeks, followed by gradual tapering over the next\u00a04\u00a0weeks. [75] Steroids have been shown to improve survival in TBM but probably do not prevent residual neurologic deficits and severe disability. [76]"}
{"id": "article-135305_55", "title": "CNS Tuberculosis -- Treatment / Management -- Anti-Inflammatory Drugs\u00a0and Supportive Therapy", "content": "Thalidomide's anti-inflammatory properties may be used to aid in recovering vision in OCA and IRIS cases. [77] Infliximab has also been shown to reduce brain inflammation in TBM with paradoxical reactions. [78] Aspirin has\u00a0demonstrated a reduced\u00a03-month stroke-related mortality rate in adults with TBM. [79] Neurocritical management of CNS-TB is also essential to interprofessional care. [80] Besides managing seizures and ischemic stroke, TBM-induced hyponatremia requires careful administration of oral salt, intravenous hypertonic saline, or, in resistant cases,\u00a0fludrocortisone. [81] [82]", "contents": "CNS Tuberculosis -- Treatment / Management -- Anti-Inflammatory Drugs\u00a0and Supportive Therapy. Thalidomide's anti-inflammatory properties may be used to aid in recovering vision in OCA and IRIS cases. [77] Infliximab has also been shown to reduce brain inflammation in TBM with paradoxical reactions. [78] Aspirin has\u00a0demonstrated a reduced\u00a03-month stroke-related mortality rate in adults with TBM. [79] Neurocritical management of CNS-TB is also essential to interprofessional care. [80] Besides managing seizures and ischemic stroke, TBM-induced hyponatremia requires careful administration of oral salt, intravenous hypertonic saline, or, in resistant cases,\u00a0fludrocortisone. [81] [82]"}
{"id": "article-135305_56", "title": "CNS Tuberculosis -- Treatment / Management -- Immune Reconstitution Inflammatory Syndrome", "content": "Clinical or radiological\u00a0deterioration\u00a0may occur several weeks after ATT initiation in approximately one-third of patients with CNS-TB\u00a0due to an aberrant immune response. [83] Significant IRIS predictors include HIV coinfection, younger age, female\u00a0sex, and shorter illness duration. [84] TB-IRIS is suspected when patients who initially improve on ATT begin demonstrating\u00a0worsening symptoms, tuberculomas with increasing size or number on imaging, or OCA aggravation.\u00a0No test currently exists to\u00a0confirm\u00a0TB-IRIS. [85] [86]", "contents": "CNS Tuberculosis -- Treatment / Management -- Immune Reconstitution Inflammatory Syndrome. Clinical or radiological\u00a0deterioration\u00a0may occur several weeks after ATT initiation in approximately one-third of patients with CNS-TB\u00a0due to an aberrant immune response. [83] Significant IRIS predictors include HIV coinfection, younger age, female\u00a0sex, and shorter illness duration. [84] TB-IRIS is suspected when patients who initially improve on ATT begin demonstrating\u00a0worsening symptoms, tuberculomas with increasing size or number on imaging, or OCA aggravation.\u00a0No test currently exists to\u00a0confirm\u00a0TB-IRIS. [85] [86]"}
{"id": "article-135305_57", "title": "CNS Tuberculosis -- Treatment / Management -- Immune Reconstitution Inflammatory Syndrome", "content": "IRIS is believed to result from a delayed type-IV hypersensitivity reaction triggered by the significant release of mycobacterial antigens and increased\u00a0tumor necrosis factor-\u03b1 and CSF lymphocytes or protein levels. IRIS\u00a0manifests with\u00a0CN deficits due to nerve entanglement\u00a0with\u00a0inflammatory exudates.\u00a0Conditions like communicating hydrocephalus, spinal arachnoiditis, and syringomyelia may also develop. However, the clinician's judgment is crucial in excluding other infections or potential treatment failure.", "contents": "CNS Tuberculosis -- Treatment / Management -- Immune Reconstitution Inflammatory Syndrome. IRIS is believed to result from a delayed type-IV hypersensitivity reaction triggered by the significant release of mycobacterial antigens and increased\u00a0tumor necrosis factor-\u03b1 and CSF lymphocytes or protein levels. IRIS\u00a0manifests with\u00a0CN deficits due to nerve entanglement\u00a0with\u00a0inflammatory exudates.\u00a0Conditions like communicating hydrocephalus, spinal arachnoiditis, and syringomyelia may also develop. However, the clinician's judgment is crucial in excluding other infections or potential treatment failure."}
{"id": "article-135305_58", "title": "CNS Tuberculosis -- Treatment / Management -- HIV Coinfection", "content": "Patients with HIV\u00a0and TBM\u00a0naive to antiretroviral therapy (ART) should begin ART 8 to 10 weeks after starting ATT. This sequence\u00a0helps avert early TB-associated IRIS\u00a0and its potentially fatal neurologic complications.\u00a0ATT and ART coadministration in patients with HIV and CNS-TB is often complicated by numerous drug interactions and higher\u00a0adverse drug reaction rates. [87]", "contents": "CNS Tuberculosis -- Treatment / Management -- HIV Coinfection. Patients with HIV\u00a0and TBM\u00a0naive to antiretroviral therapy (ART) should begin ART 8 to 10 weeks after starting ATT. This sequence\u00a0helps avert early TB-associated IRIS\u00a0and its potentially fatal neurologic complications.\u00a0ATT and ART coadministration in patients with HIV and CNS-TB is often complicated by numerous drug interactions and higher\u00a0adverse drug reaction rates. [87]"}
{"id": "article-135305_59", "title": "CNS Tuberculosis -- Treatment / Management -- Shunt Surgery in\u00a0Tuberculous Meningitis", "content": "Communicating hydrocephalus is initially managed with corticosteroids, the carbonic anhydrase inhibitor\u00a0acetazolamide, and osmotic diuretics\u00a0like\u00a0mannitol and glycerol.\u00a0Temporary external ventricular drainage is\u00a0also used for CSF drainage. [88] Endoscopic third ventriculostomy (ETV) has been reported to have a success rate of 73% to 89%. [89] ETV has fewer complications and may be more beneficial\u00a0than\u00a0ventriculoperitoneal\u00a0shunt (VPS) placement. However, ETV\u00a0is likely to fail during the illness' initial stages,\u00a0in which case, VPS surgery may be performed. [90] [91] . The outcome of patients treated with\u00a0VPS\u00a0placement depends considerably on the TBM clinical stage. [92]", "contents": "CNS Tuberculosis -- Treatment / Management -- Shunt Surgery in\u00a0Tuberculous Meningitis. Communicating hydrocephalus is initially managed with corticosteroids, the carbonic anhydrase inhibitor\u00a0acetazolamide, and osmotic diuretics\u00a0like\u00a0mannitol and glycerol.\u00a0Temporary external ventricular drainage is\u00a0also used for CSF drainage. [88] Endoscopic third ventriculostomy (ETV) has been reported to have a success rate of 73% to 89%. [89] ETV has fewer complications and may be more beneficial\u00a0than\u00a0ventriculoperitoneal\u00a0shunt (VPS) placement. However, ETV\u00a0is likely to fail during the illness' initial stages,\u00a0in which case, VPS surgery may be performed. [90] [91] . The outcome of patients treated with\u00a0VPS\u00a0placement depends considerably on the TBM clinical stage. [92]"}
{"id": "article-135305_60", "title": "CNS Tuberculosis -- Treatment / Management -- Shunt Surgery in\u00a0Tuberculous Meningitis", "content": "Vellore and modified Vellore grading systems have been validated for patients with TBM with hydrocephalus to aid in surgical decision-making and predict the success of\u00a0VPS\u00a0surgery and ETV. The grades vary from 1 to 4, increasing in disease severity. The modified version incorporates the Glasgow Coma Scale score. The management of patients\u00a0with\u00a0grade 4 TBM is still contentious. [93]", "contents": "CNS Tuberculosis -- Treatment / Management -- Shunt Surgery in\u00a0Tuberculous Meningitis. Vellore and modified Vellore grading systems have been validated for patients with TBM with hydrocephalus to aid in surgical decision-making and predict the success of\u00a0VPS\u00a0surgery and ETV. The grades vary from 1 to 4, increasing in disease severity. The modified version incorporates the Glasgow Coma Scale score. The management of patients\u00a0with\u00a0grade 4 TBM is still contentious. [93]"}
{"id": "article-135305_61", "title": "CNS Tuberculosis -- Differential Diagnosis", "content": "TBM presents a significant diagnostic challenge due to its broad range of potential mimics. Meticulous exclusion of other causes of chronic meningitis or meningoencephalitis is crucial, especially in immunocompromised individuals. Conditions such as fungal meningitis (particularly cryptococcal meningitis), neurobrucellosis, neurosyphilis, neuroborreliosis, and neurosarcoidosis may mimic TBM. Partially treated bacterial meningitis, neoplastic meningitis, or systemic inflammation involving the CNS should also be considered in\u00a0appropriate\u00a0clinical settings. Neuroradiology and neuropathology\u00a0are pivotal in aiding clinicians in these diagnostic challenges.", "contents": "CNS Tuberculosis -- Differential Diagnosis. TBM presents a significant diagnostic challenge due to its broad range of potential mimics. Meticulous exclusion of other causes of chronic meningitis or meningoencephalitis is crucial, especially in immunocompromised individuals. Conditions such as fungal meningitis (particularly cryptococcal meningitis), neurobrucellosis, neurosyphilis, neuroborreliosis, and neurosarcoidosis may mimic TBM. Partially treated bacterial meningitis, neoplastic meningitis, or systemic inflammation involving the CNS should also be considered in\u00a0appropriate\u00a0clinical settings. Neuroradiology and neuropathology\u00a0are pivotal in aiding clinicians in these diagnostic challenges."}
{"id": "article-135305_62", "title": "CNS Tuberculosis -- Differential Diagnosis", "content": "Tuberculoma\u00a0has similar clinical features and radiological appearance\u00a0as neurocysticercosis, cryptococcoma, CNS lymphoma, and primary or metastatic brain tumor. Focal encephalitides like herpes simplex and parameningeal infections like brain abscesses\u00a0may occasionally behave similarly to CNS tuberculoma. CNS toxoplasmosis requires careful consideration in cases of HIV coinfection.", "contents": "CNS Tuberculosis -- Differential Diagnosis. Tuberculoma\u00a0has similar clinical features and radiological appearance\u00a0as neurocysticercosis, cryptococcoma, CNS lymphoma, and primary or metastatic brain tumor. Focal encephalitides like herpes simplex and parameningeal infections like brain abscesses\u00a0may occasionally behave similarly to CNS tuberculoma. CNS toxoplasmosis requires careful consideration in cases of HIV coinfection."}
{"id": "article-135305_63", "title": "CNS Tuberculosis -- Differential Diagnosis", "content": "Spinal arachnoiditis needs to be differentiated\u00a0from an intradural spinal tuberculoma, extradural compressive myelopathy due to tuberculous spondylitis with paravertebral cold abscess, noncompressive acute transverse myelitis, and Guillain-Barre syndrome. Cytomegalovirus polyradiculopathy can confuse the picture in people with HIV.", "contents": "CNS Tuberculosis -- Differential Diagnosis. Spinal arachnoiditis needs to be differentiated\u00a0from an intradural spinal tuberculoma, extradural compressive myelopathy due to tuberculous spondylitis with paravertebral cold abscess, noncompressive acute transverse myelitis, and Guillain-Barre syndrome. Cytomegalovirus polyradiculopathy can confuse the picture in people with HIV."}
{"id": "article-135305_64", "title": "CNS Tuberculosis -- Pertinent Studies and Ongoing Trials", "content": "Developments in the fields of host immune responses, pathogenesis, and\u00a0tuberculosis diagnosis and treatment are happening globally. [94] Emerging techniques\u00a0for rapid TBM diagnosis include measuring new biomarkers like CSF lactate, mNGS, cell-free DNA analysis, clustered regularly interspaced short palindromic repeats (CRISPR)\u00a0technology for detecting low MTB levels in CSF, and peripheral blood microRNA detection using transcriptomic techniques. [95] Human genetic polymorphisms that can explain the heterogeneity of host immune response to anti-inflammatory therapies are being identified. Genomic and metabolomic studies are determining\u00a0survival-predicting CSF biomarkers (\u03b1\u03b2 T-cells, natural killer cells, and pro-resolving mediators) that may be used to tailor and individualize therapy. [96] [97]", "contents": "CNS Tuberculosis -- Pertinent Studies and Ongoing Trials. Developments in the fields of host immune responses, pathogenesis, and\u00a0tuberculosis diagnosis and treatment are happening globally. [94] Emerging techniques\u00a0for rapid TBM diagnosis include measuring new biomarkers like CSF lactate, mNGS, cell-free DNA analysis, clustered regularly interspaced short palindromic repeats (CRISPR)\u00a0technology for detecting low MTB levels in CSF, and peripheral blood microRNA detection using transcriptomic techniques. [95] Human genetic polymorphisms that can explain the heterogeneity of host immune response to anti-inflammatory therapies are being identified. Genomic and metabolomic studies are determining\u00a0survival-predicting CSF biomarkers (\u03b1\u03b2 T-cells, natural killer cells, and pro-resolving mediators) that may be used to tailor and individualize therapy. [96] [97]"}
{"id": "article-135305_65", "title": "CNS Tuberculosis -- Pertinent Studies and Ongoing Trials", "content": "Advanced imaging techniques and sequences like 3-dimensional magnetization-prepared rapid gradient-echo are being studied to better delineate brain lesions. Phase-contrast MRI is another novel and sensitive technique\u00a0that helps\u00a0assess altered CSF flow dynamics in patients with TBM. [98]", "contents": "CNS Tuberculosis -- Pertinent Studies and Ongoing Trials. Advanced imaging techniques and sequences like 3-dimensional magnetization-prepared rapid gradient-echo are being studied to better delineate brain lesions. Phase-contrast MRI is another novel and sensitive technique\u00a0that helps\u00a0assess altered CSF flow dynamics in patients with TBM. [98]"}
{"id": "article-135305_66", "title": "CNS Tuberculosis -- Pertinent Studies and Ongoing Trials", "content": "Novel promising drugs such as linezolid, bedaquiline, and pretomanid are being tested in various combinations, especially in highly drug-resistant\u00a0MTB therapy. [99] Clinical trials currently examine the effectiveness of high-dose RIF and fluoroquinolones. A combination of intravenous INH, high-dose RIF, and ETB are also in the pipeline. [100]", "contents": "CNS Tuberculosis -- Pertinent Studies and Ongoing Trials. Novel promising drugs such as linezolid, bedaquiline, and pretomanid are being tested in various combinations, especially in highly drug-resistant\u00a0MTB therapy. [99] Clinical trials currently examine the effectiveness of high-dose RIF and fluoroquinolones. A combination of intravenous INH, high-dose RIF, and ETB are also in the pipeline. [100]"}
{"id": "article-135305_67", "title": "CNS Tuberculosis -- Pertinent Studies and Ongoing Trials", "content": "Aspirin is being investigated as an adjunctive treatment to reduce infarction incidence\u00a0due to its ability to\u00a0inhibit CSF thromboxane A2 and upregulate pre-resolvins. [101] Adjunctive anti-tumor necrosis factor-\u03b1, interferon-\u03b3,\u00a0and\u00a0thalidomide have also been tried to modulate host immune response.\u00a0Suitable strategies are likewise being designed and implemented to accomplish the End Tuberculosis Strategy's global targets. [102] [103]", "contents": "CNS Tuberculosis -- Pertinent Studies and Ongoing Trials. Aspirin is being investigated as an adjunctive treatment to reduce infarction incidence\u00a0due to its ability to\u00a0inhibit CSF thromboxane A2 and upregulate pre-resolvins. [101] Adjunctive anti-tumor necrosis factor-\u03b1, interferon-\u03b3,\u00a0and\u00a0thalidomide have also been tried to modulate host immune response.\u00a0Suitable strategies are likewise being designed and implemented to accomplish the End Tuberculosis Strategy's global targets. [102] [103]"}
{"id": "article-135305_68", "title": "CNS Tuberculosis -- Toxicity and Adverse Effect Management", "content": "ATT is generally well tolerated.\u00a0However, close follow-up is needed to monitor any adverse drug reactions that may arise due to the drugs' cumulative effects and long\u00a0exposure duration. [104] All\u00a0ATT drugs have specific side effects\u00a0besides gastrointestinal intolerance and fatigue. Factors such as HIV coinfection, drug resistance, and steroid prescription can exacerbate the problem. INH, RMP, and PZA are all hepatotoxic. INH can also cause peripheral neuropathy, but this reaction may be prevented by pyridoxine supplementation. INH can cause lupus-like symptoms, pellagra, and psychosis in rare instances. RMP discolors the urine and may cause rashes, influenza-like illness, and thrombocytopenia.", "contents": "CNS Tuberculosis -- Toxicity and Adverse Effect Management. ATT is generally well tolerated.\u00a0However, close follow-up is needed to monitor any adverse drug reactions that may arise due to the drugs' cumulative effects and long\u00a0exposure duration. [104] All\u00a0ATT drugs have specific side effects\u00a0besides gastrointestinal intolerance and fatigue. Factors such as HIV coinfection, drug resistance, and steroid prescription can exacerbate the problem. INH, RMP, and PZA are all hepatotoxic. INH can also cause peripheral neuropathy, but this reaction may be prevented by pyridoxine supplementation. INH can cause lupus-like symptoms, pellagra, and psychosis in rare instances. RMP discolors the urine and may cause rashes, influenza-like illness, and thrombocytopenia."}
{"id": "article-135305_69", "title": "CNS Tuberculosis -- Toxicity and Adverse Effect Management", "content": "ETB may produce\u00a0dose-dependent optic neuritis and peripheral neuropathy. PZA may give rise to various cutaneous reactions, asymptomatic hyperuricemia, and gouty arthritis. Streptomycin is associated with ototoxicity, vertigo, and injection site pain. The novel drug bedaquiline is associated with QT prolongation\u00a0on electrocardiography.", "contents": "CNS Tuberculosis -- Toxicity and Adverse Effect Management. ETB may produce\u00a0dose-dependent optic neuritis and peripheral neuropathy. PZA may give rise to various cutaneous reactions, asymptomatic hyperuricemia, and gouty arthritis. Streptomycin is associated with ototoxicity, vertigo, and injection site pain. The novel drug bedaquiline is associated with QT prolongation\u00a0on electrocardiography."}
{"id": "article-135305_70", "title": "CNS Tuberculosis -- Toxicity and Adverse Effect Management", "content": "All patients on ATT should have liver monitoring during the initial\u00a08 weeks of treatment.\u00a0An\u00a0asymptomatic rise in hepatic transaminases is expected at the beginning of therapy.\u00a0Hepatotoxic drugs should be replaced with 2nd- or 3rd-line\u00a0options if transaminase levels exceed 3\u00a0to 5 times the upper limit of normal or serum bilirubin increases beyond\u00a02.5 mg/L. [105] [106]", "contents": "CNS Tuberculosis -- Toxicity and Adverse Effect Management. All patients on ATT should have liver monitoring during the initial\u00a08 weeks of treatment.\u00a0An\u00a0asymptomatic rise in hepatic transaminases is expected at the beginning of therapy.\u00a0Hepatotoxic drugs should be replaced with 2nd- or 3rd-line\u00a0options if transaminase levels exceed 3\u00a0to 5 times the upper limit of normal or serum bilirubin increases beyond\u00a02.5 mg/L. [105] [106]"}
{"id": "article-135305_71", "title": "CNS Tuberculosis -- Staging", "content": "TBM is classified into clinical stages based on illness severity when treatment begins. These stages help prognosticate and decide on therapy. [107] [108] The\u00a0TBM stages are defined as follows: Stage I: The patient is alert and conscious\u00a0with no focal neurological signs or hydrocephalus. Stage II: The patient is confused or irritable\u00a0and has few focal signs, such as CN palsies or hemiparesis. Stage III: The patient is comatose with or without dense neurological deficit and may be in decerebrate or decorticate posturing.", "contents": "CNS Tuberculosis -- Staging. TBM is classified into clinical stages based on illness severity when treatment begins. These stages help prognosticate and decide on therapy. [107] [108] The\u00a0TBM stages are defined as follows: Stage I: The patient is alert and conscious\u00a0with no focal neurological signs or hydrocephalus. Stage II: The patient is confused or irritable\u00a0and has few focal signs, such as CN palsies or hemiparesis. Stage III: The patient is comatose with or without dense neurological deficit and may be in decerebrate or decorticate posturing."}
{"id": "article-135305_72", "title": "CNS Tuberculosis -- Prognosis", "content": "CNS-TB's prognosis is dismal even after therapy. TBM's mortality ranges between 9.8%\u00a0and 57%,\u00a0as it is associated with distressing levels of neurologic sequelae that disproportionately afflict children. [109] Various mortality and neurological morbidity predictors\u00a0have been identified, including age, symptom duration, Glasgow Coma Scale score, absence of headache, CSF protein level, arachnoiditis extent, presence of complications, and Medical Research Council staging at presentation. [110]", "contents": "CNS Tuberculosis -- Prognosis. CNS-TB's prognosis is dismal even after therapy. TBM's mortality ranges between 9.8%\u00a0and 57%,\u00a0as it is associated with distressing levels of neurologic sequelae that disproportionately afflict children. [109] Various mortality and neurological morbidity predictors\u00a0have been identified, including age, symptom duration, Glasgow Coma Scale score, absence of headache, CSF protein level, arachnoiditis extent, presence of complications, and Medical Research Council staging at presentation. [110]"}
{"id": "article-135305_73", "title": "CNS Tuberculosis -- Complications", "content": "CNS-TB can be lethal or cause devastating complications. The initial complications\u00a0arise from\u00a0pachymeningitis, leading to hydrocephalus, OCA-related visual loss, focal neurological deficits, stroke, arteritis-induced hemiplegias, cerebral edema, tuberculoma- or abscess-induced seizures, and diabetes insipidus or syndrome of inappropriate antidiuretic hormone secretion. Myelitis complicates TBM in 10% of cases and is an independent\u00a0predictor of poor outcomes. [111] Around\u00a010% to 30% of patients with TBM\u00a0develop long-term residual neurologic deficits, including the above complications,\u00a0besides learning disabilities, dementia, endocrine syndromes, and gait disturbances.", "contents": "CNS Tuberculosis -- Complications. CNS-TB can be lethal or cause devastating complications. The initial complications\u00a0arise from\u00a0pachymeningitis, leading to hydrocephalus, OCA-related visual loss, focal neurological deficits, stroke, arteritis-induced hemiplegias, cerebral edema, tuberculoma- or abscess-induced seizures, and diabetes insipidus or syndrome of inappropriate antidiuretic hormone secretion. Myelitis complicates TBM in 10% of cases and is an independent\u00a0predictor of poor outcomes. [111] Around\u00a010% to 30% of patients with TBM\u00a0develop long-term residual neurologic deficits, including the above complications,\u00a0besides learning disabilities, dementia, endocrine syndromes, and gait disturbances."}
{"id": "article-135305_74", "title": "CNS Tuberculosis -- Postoperative and Rehabilitation Care", "content": "TBM necessitates intensive rehabilitation\u00a0and optimal medical treatment to reduce disability and facilitate recovery. Rehabilitation should commence during hospitalization or in the intensive care unit and extend into the home postdischarge.\u00a0Rehabilitative efforts should encompass multimodal sensory stimulation to enhance brain function recovery, scheduled posturing and positioning to prevent immobilization complications, passive and active range of motion exercises to maintain muscle strength, and chest physiotherapy to mitigate pneumonia and aspiration risks. Long-term rehabilitation is essential for patients with lingering neurological impairments [112]", "contents": "CNS Tuberculosis -- Postoperative and Rehabilitation Care. TBM necessitates intensive rehabilitation\u00a0and optimal medical treatment to reduce disability and facilitate recovery. Rehabilitation should commence during hospitalization or in the intensive care unit and extend into the home postdischarge.\u00a0Rehabilitative efforts should encompass multimodal sensory stimulation to enhance brain function recovery, scheduled posturing and positioning to prevent immobilization complications, passive and active range of motion exercises to maintain muscle strength, and chest physiotherapy to mitigate pneumonia and aspiration risks. Long-term rehabilitation is essential for patients with lingering neurological impairments [112]"}
{"id": "article-135305_75", "title": "CNS Tuberculosis -- Consultations", "content": "Specialists in the following\u00a0disciplines should be consulted for comprehensive CNS-TB management: Infectious disease Neuroradiology Neurology Neurosurgery Ophthalmology Physiotherapy", "contents": "CNS Tuberculosis -- Consultations. Specialists in the following\u00a0disciplines should be consulted for comprehensive CNS-TB management: Infectious disease Neuroradiology Neurology Neurosurgery Ophthalmology Physiotherapy"}
{"id": "article-135305_76", "title": "CNS Tuberculosis -- Deterrence and Patient Education", "content": "Patients and their caregivers\u00a0must be educated about medication compliance, as CNS-TB requires prolonged treatment. These individuals\u00a0must be enlightened about the potential disease- and treatment-related complications.\u00a0Patients and their families should be counseled for regular hospital visits, investigations, and close follow-ups to ensure disease resolution and prevent\u00a0adverse drug reactions.", "contents": "CNS Tuberculosis -- Deterrence and Patient Education. Patients and their caregivers\u00a0must be educated about medication compliance, as CNS-TB requires prolonged treatment. These individuals\u00a0must be enlightened about the potential disease- and treatment-related complications.\u00a0Patients and their families should be counseled for regular hospital visits, investigations, and close follow-ups to ensure disease resolution and prevent\u00a0adverse drug reactions."}
{"id": "article-135305_77", "title": "CNS Tuberculosis -- Pearls and Other Issues -- Pearls", "content": "CNS-TB poses a diagnostic and therapeutic challenge due to its paucibacillary nature and diverse clinical manifestations. Diagnosis hinges on a combination of clinical suspicion, imaging,\u00a0CSF analysis, and molecular techniques like Xpert MTB/RIF. Early and accurate diagnosis is crucial, as delayed\u00a0treatment may lead to serious morbidity and mortality.\u00a0Treatment involves\u00a0ATT and adjunctive corticosteroids, with surgical intervention reserved for specific complications. Monitoring for paradoxical reactions and IRIS is essential during treatment. Long-term neurorehabilitation may be necessary for patients with residual neurological deficits. Interprofessional collaboration is paramount for optimizing outcomes in CNS-TB management.", "contents": "CNS Tuberculosis -- Pearls and Other Issues -- Pearls. CNS-TB poses a diagnostic and therapeutic challenge due to its paucibacillary nature and diverse clinical manifestations. Diagnosis hinges on a combination of clinical suspicion, imaging,\u00a0CSF analysis, and molecular techniques like Xpert MTB/RIF. Early and accurate diagnosis is crucial, as delayed\u00a0treatment may lead to serious morbidity and mortality.\u00a0Treatment involves\u00a0ATT and adjunctive corticosteroids, with surgical intervention reserved for specific complications. Monitoring for paradoxical reactions and IRIS is essential during treatment. Long-term neurorehabilitation may be necessary for patients with residual neurological deficits. Interprofessional collaboration is paramount for optimizing outcomes in CNS-TB management."}
{"id": "article-135305_78", "title": "CNS Tuberculosis -- Pearls and Other Issues -- Other Issues", "content": "A discussion of spinal tuberculosis is relevant in this section due to its overlapping neurological presentations with CNS-TB. Spinal tuberculosis, a subset of skeletal tuberculosis, manifests as spondylodiscitis or spondylitis without intervertebral disk involvement. [113] In adults, intervertebral disk involvement often results from contiguous spread from infected vertebrae.\u00a0In children, hematogenous spread may lead to TB diskitis due to the area's rich vascular supply.\u00a0Pott disease is characterized by osteomyelitis and arthritis and typically affects multiple vertebrae.\u00a0The condition produces progressive vertebral destruction, anterior collapse, kyphotic or gibbous deformity (in thoracic vertebrae), paraspinal cold abscess formation, and spinal canal narrowing. These complications can culminate in various neurological deficits, with paraplegia being the most devastating. [114]", "contents": "CNS Tuberculosis -- Pearls and Other Issues -- Other Issues. A discussion of spinal tuberculosis is relevant in this section due to its overlapping neurological presentations with CNS-TB. Spinal tuberculosis, a subset of skeletal tuberculosis, manifests as spondylodiscitis or spondylitis without intervertebral disk involvement. [113] In adults, intervertebral disk involvement often results from contiguous spread from infected vertebrae.\u00a0In children, hematogenous spread may lead to TB diskitis due to the area's rich vascular supply.\u00a0Pott disease is characterized by osteomyelitis and arthritis and typically affects multiple vertebrae.\u00a0The condition produces progressive vertebral destruction, anterior collapse, kyphotic or gibbous deformity (in thoracic vertebrae), paraspinal cold abscess formation, and spinal canal narrowing. These complications can culminate in various neurological deficits, with paraplegia being the most devastating. [114]"}
{"id": "article-135305_79", "title": "CNS Tuberculosis -- Pearls and Other Issues -- Other Issues", "content": "Early-onset paraplegia may occur due to mechanical compression by tuberculous debris, bone or disk sequestrum, tuberculomas, granulomas, or abscess in extradural, intradural, or intramedullary regions, myelitis with cord edema, meningeal inflammation, and anterior spinal artery thrombosis\u00a0with cord infarction. Frank infarction is rare\u00a0since the smaller end-arteries are involved. [115]", "contents": "CNS Tuberculosis -- Pearls and Other Issues -- Other Issues. Early-onset paraplegia may occur due to mechanical compression by tuberculous debris, bone or disk sequestrum, tuberculomas, granulomas, or abscess in extradural, intradural, or intramedullary regions, myelitis with cord edema, meningeal inflammation, and anterior spinal artery thrombosis\u00a0with cord infarction. Frank infarction is rare\u00a0since the smaller end-arteries are involved. [115]"}
{"id": "article-135305_80", "title": "CNS Tuberculosis -- Pearls and Other Issues -- Other Issues", "content": "Late-onset paraplegia in severe kyphosis may result from cord transection by a transverse bony ridge or dural fibrosis with cord encasement and, occasionally, syrinx formation. Paraspinal abscesses may mechanically compress the cord depending on their location. Retropharyngeal abscesses may cause dysphagia and respiratory distress.\u00a0Mediastinal lesions can track down to the trachea, esophagus, or pleural cavity. Tuberculous abscesses may present as fusiform or bulbous paravertebral swelling in the thoracic region and groin or medial thigh bulging in the lumbar area.", "contents": "CNS Tuberculosis -- Pearls and Other Issues -- Other Issues. Late-onset paraplegia in severe kyphosis may result from cord transection by a transverse bony ridge or dural fibrosis with cord encasement and, occasionally, syrinx formation. Paraspinal abscesses may mechanically compress the cord depending on their location. Retropharyngeal abscesses may cause dysphagia and respiratory distress.\u00a0Mediastinal lesions can track down to the trachea, esophagus, or pleural cavity. Tuberculous abscesses may present as fusiform or bulbous paravertebral swelling in the thoracic region and groin or medial thigh bulging in the lumbar area."}
{"id": "article-135305_81", "title": "CNS Tuberculosis -- Pearls and Other Issues -- Other Issues", "content": "For neuroimaging, spinal CT scans offer detailed bony information, while MRI is essential for evaluating soft tissue components (see Images . Spinal Cord Tuberculoma, Pott Spine). Spinal\u00a0tuberculosis typically spares the intervertebral disc, shows vertebral endplate rarefaction and\u00a0anterior vertebral wedging, and may present with paravertebral abscesses. Neuroimaging-guided needle biopsy\u00a0of the involved vertebral body is the diagnostic gold standard. Pott spine treatment involves standard ATT, with the continuation phase potentially extending up to 18 months. Surgery for\u00a0this condition is indicated in cases of neurological deficits, large paravertebral abscesses, and spinal instability.", "contents": "CNS Tuberculosis -- Pearls and Other Issues -- Other Issues. For neuroimaging, spinal CT scans offer detailed bony information, while MRI is essential for evaluating soft tissue components (see Images . Spinal Cord Tuberculoma, Pott Spine). Spinal\u00a0tuberculosis typically spares the intervertebral disc, shows vertebral endplate rarefaction and\u00a0anterior vertebral wedging, and may present with paravertebral abscesses. Neuroimaging-guided needle biopsy\u00a0of the involved vertebral body is the diagnostic gold standard. Pott spine treatment involves standard ATT, with the continuation phase potentially extending up to 18 months. Surgery for\u00a0this condition is indicated in cases of neurological deficits, large paravertebral abscesses, and spinal instability."}
{"id": "article-135305_82", "title": "CNS Tuberculosis -- Enhancing Healthcare Team Outcomes", "content": "CNS-TB, though rare, profoundly affects both the quantity and quality of life. Screening for active infected cases in high tuberculosis-burden settings may help prevent CNS-TB. Treatment adherence significantly influences outcomes once diagnosed. While most countries have national policies in place, embracing global evidence-based approaches to CNS-TB management is essential for ensuring optimal patient care and support. [116]", "contents": "CNS Tuberculosis -- Enhancing Healthcare Team Outcomes. CNS-TB, though rare, profoundly affects both the quantity and quality of life. Screening for active infected cases in high tuberculosis-burden settings may help prevent CNS-TB. Treatment adherence significantly influences outcomes once diagnosed. While most countries have national policies in place, embracing global evidence-based approaches to CNS-TB management is essential for ensuring optimal patient care and support. [116]"}
{"id": "article-135305_83", "title": "CNS Tuberculosis -- Enhancing Healthcare Team Outcomes", "content": "CNS-TB requires comprehensive and coordinated team care to enhance patient outcomes. Each team member, including the treating clinician, infectious disease specialist, neuroradiologist, neurologist, neurosurgeon, ophthalmologist, nurse, and pharmacist, holds individual and collaborative responsibilities. Nurses are crucial for overall patient care, while pharmacists, especially infectious disease-specialized pharmacists,\u00a0are vital\u00a0during drug selection, medication reconciliation, dosing regimens, adjustments, and patient counseling. [117] [118] Effective communication with prescribing clinicians is essential for pharmacists to modify therapy appropriately in response to patient status changes.", "contents": "CNS Tuberculosis -- Enhancing Healthcare Team Outcomes. CNS-TB requires comprehensive and coordinated team care to enhance patient outcomes. Each team member, including the treating clinician, infectious disease specialist, neuroradiologist, neurologist, neurosurgeon, ophthalmologist, nurse, and pharmacist, holds individual and collaborative responsibilities. Nurses are crucial for overall patient care, while pharmacists, especially infectious disease-specialized pharmacists,\u00a0are vital\u00a0during drug selection, medication reconciliation, dosing regimens, adjustments, and patient counseling. [117] [118] Effective communication with prescribing clinicians is essential for pharmacists to modify therapy appropriately in response to patient status changes."}
{"id": "article-135305_84", "title": "CNS Tuberculosis -- Enhancing Healthcare Team Outcomes", "content": "Effective communication and collaboration\u00a0within the healthcare team are essential for shared decision-making to reduce complications and expedite recovery in critically ill patients. [119] Improved\u00a0infection control modalities and surveillance are necessary to screen and diagnose patients efficiently and provide interprofessional services to affected individuals.", "contents": "CNS Tuberculosis -- Enhancing Healthcare Team Outcomes. Effective communication and collaboration\u00a0within the healthcare team are essential for shared decision-making to reduce complications and expedite recovery in critically ill patients. [119] Improved\u00a0infection control modalities and surveillance are necessary to screen and diagnose patients efficiently and provide interprofessional services to affected individuals."}
{"id": "article-135305_85", "title": "CNS Tuberculosis -- Enhancing Healthcare Team Outcomes", "content": "Most countries release evidence-based guidelines for managing PTB and EPTB without considering each patient's unique circumstances, geographic location, and healthcare setting. Clinical decisions\u00a0must be individualized\u00a0to enhance health outcomes. [120]", "contents": "CNS Tuberculosis -- Enhancing Healthcare Team Outcomes. Most countries release evidence-based guidelines for managing PTB and EPTB without considering each patient's unique circumstances, geographic location, and healthcare setting. Clinical decisions\u00a0must be individualized\u00a0to enhance health outcomes. [120]"}
{"id": "article-135305_86", "title": "CNS Tuberculosis -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "CNS Tuberculosis -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}